ReShape Lifesciences (HIND) Operating Margin (2015 - 2026)
ReShape Lifesciences (HIND) operating margin from Sep 30, 2015 to Mar 31, 2026. The current ReShape Lifesciences (HIND) operating margin is -3766.67%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of ReShape Lifesciences (HIND)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -3265.63% | +25798.67% |
| 2024 | -12.61% | -92.88% |
| 2023 | -177.19% | -57.03% |
| 2022 | -412.37% | -3.11% |
| 2021 | -425.59% | +285.97% |
| 2020 | -110.27% | -84.43% |
| 2019 | -708.23% | +74.33% |
| 2018 | -406.26% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | -347.02% | +5.93% |
| 2017 | -327.60% | -15.96% |
| 2017 | -389.80% | -25.49% |
| 2017 | -523.13% | -9.06% |
| 2016 | -575.22% | -0.47% |
| 2016 | -577.92% | +10.76% |
| 2016 | -521.79% | +62.30% |
| 2016 | -321.50% | -13.00% |
| 2015 | -369.55% | +19.53% |
| 2015 | -309.17% | -33.34% |
| 2015 | -463.81% | +108.94% |
| 2015 | -221.98% | -20.14% |
| 2014 | -277.97% | N/A |
Comparison ReShape Lifesciences (HIND) operating margin with competitors
ReShape Lifesciences (HIND) operating margin is -3766.67%.